FATUZZO, Pasquale Mario
 Distribuzione geografica
Continente #
NA - Nord America 6.975
EU - Europa 2.981
AS - Asia 2.055
SA - Sud America 269
AF - Africa 221
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 12.509
Nazione #
US - Stati Uniti d'America 6.701
SG - Singapore 1.140
IE - Irlanda 809
UA - Ucraina 794
CN - Cina 792
IT - Italia 708
CA - Canada 272
BR - Brasile 251
RU - Federazione Russa 219
CI - Costa d'Avorio 179
DE - Germania 171
SE - Svezia 94
GB - Regno Unito 50
FR - Francia 33
IN - India 33
SN - Senegal 31
VN - Vietnam 24
CH - Svizzera 23
UZ - Uzbekistan 19
GR - Grecia 15
AT - Austria 13
NL - Olanda 12
PL - Polonia 11
AR - Argentina 10
IR - Iran 7
LB - Libano 7
TR - Turchia 7
AL - Albania 6
BD - Bangladesh 5
FI - Finlandia 5
CZ - Repubblica Ceca 4
EU - Europa 4
IQ - Iraq 4
CO - Colombia 3
HK - Hong Kong 3
HU - Ungheria 3
MA - Marocco 3
NP - Nepal 3
AU - Australia 2
BG - Bulgaria 2
EG - Egitto 2
KE - Kenya 2
MX - Messico 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
SM - San Marino 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
DZ - Algeria 1
ES - Italia 1
ET - Etiopia 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 12.509
Città #
Houston 1.253
Santa Clara 978
Jacksonville 870
Dublin 809
Chandler 722
Singapore 636
Boardman 349
Chicago 288
Nanjing 271
Andover 236
Lawrence 234
Cambridge 233
Toronto 218
Abidjan 179
Des Moines 135
San Mateo 119
Catania 112
Wilmington 104
Ashburn 98
Grafing 96
Nanchang 81
Shenyang 81
Saint Petersburg 77
Civitanova Marche 61
Hebei 57
Ottawa 52
Jiaxing 50
Changsha 43
Rome 41
Tianjin 39
Bremen 33
Dakar 31
Council Bluffs 26
Beijing 24
Los Angeles 21
Milan 21
Dong Ket 20
Pune 20
Seattle 17
Norwalk 16
Moscow 15
Rio de Janeiro 14
São Paulo 14
Florence 13
Hangzhou 13
Padova 12
Kunming 11
Ningbo 11
Noto 11
Zhengzhou 11
Jinan 10
Liberty Lake 10
Carlentini 9
Civitavecchia 9
Guangzhou 9
Monteiasi 8
Guarulhos 7
Messina 7
Washington 7
Ardabil 6
Bari 6
Falls Church 6
Frankfurt Am Main 6
Praia Grande 6
Taizhou 6
Ann Arbor 5
Brasília 5
Changchun 5
Den Haag 5
Munich 5
Palermo 5
San Giovanni la Punta 5
Tirana 5
Aci Sant'antonio 4
Belo Horizonte 4
Curitiba 4
Hanoi 4
Helsinki 4
Kiev 4
Monmouth Junction 4
Mumbai 4
Naples 4
New York 4
Porto Alegre 4
Reggio Emilia 4
Salvador 4
Springfield 4
Syracuse 4
São José dos Pinhais 4
Tappahannock 4
Trento 4
Venezia 4
Acquasparta 3
Amsterdam 3
Augusta 3
Baghdad 3
Cagliari 3
Campinas 3
Carnago 3
Caserta 3
Totale 9.128
Nome #
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients 902
Molecular and clinical studies in five index cases with novel mutations in the GLA gene 271
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 236
LA DIMETILARGININA ASIMMETRICA (ADMA) INTERAGISCE CON L’FGF-23 NEL PREDIRE LA PROGRESSIONE DEL DANNO RENALE NEI PAZIENTI CON STADIO 2-5 DI MALATTIA RENALE CRONICA 158
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 104
Microplastics exposure in dialysis patients: preliminary results of a case-control study 99
Comparison of the CBA-H and SF-36 for the screening of the psychological and behavioural variables in chronic dialysis patients. 99
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention 96
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 92
Aferesi terapeutica in paziente con crioglobulinemia (contributo clinico) 88
Il Fosforo: nuovo fattore di rischio cardiovascolare? [Phosphorus: A new cardiovascular risk factor?] 85
Aberrant right subclavian artery laceration due to internal jugular vein catheterization treated by stent -graft implantation 80
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease 79
Pazienti con insufficienza renale cronica:risultati dallo studio Nefrodata® 78
A systematic review of arterial stiffness, wave reflection and air pollution 77
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVELS IN CHRONIC KIDNEY DISEASE: A SALTY QUESTION? 76
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 76
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 76
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics 75
ADPKD: valutazione di patologia cistica epididimaria e quadro spermatico 74
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . 73
Soluble E-selectina is an marker of outcome in end renal disease and interacts with inflammation to determine cardiovascular risk 73
Rapporti dei peptidi natriuretici con la struttura e la funzione cardiaca nell'insufficienza renale cronica terminale: analogie e differenze tra ANP, BNP, CNP e DNP. 71
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 71
Utilità dell’sCD14-ST per la diagnosi di sepsi nel paziente con insufficienza renale [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure] 70
LIVELLI PLASMATICI DELLE PENTRAXINE “SHORT” (PROTEINA C REATTIVA) E DELLE PENTRAXINE “LONG” (PTX3) NELLA INSUFFICIENZA RENALE E NEL TRATTAMENTO EMODIALITICO 70
Wegener: nostro contributo clinico 70
Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function 70
Peritonite da Candida e sepsi da Acinetobacter baumannii in dialisi peritoneale: una associazione con la prognosi non è sempre sfavorevole 69
Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study". 68
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients 67
ITALIAN AUDIT ON THERAPY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE: TABLE-CKD STUDY 67
L’IMMUNITÀ INNATA E LA PROGRESSIONE DELLA MALATTIA RENALE CRONICA 67
Eventi avversi e trigger C12: Stroke in ospedale 67
raised Asymmetric Dimethyl Arginine is Associated With High Plasma Norepinephrine in Patients with ESRD 66
Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and Left Atrial Volume: a longitudinal study in End Stage Renal Disease (ESRD) patients. JASN 2008;19:719A. 66
Asymmetric dimethylarginine (ADMA),left ventricular hypertrophy and systolic dysfunction in hemodialysis patients 66
Arterial pressure determinant of LVH in uremic patients. 66
Vascular dysfunction in Cardiorenal Syndrome type 4 66
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease 66
Valutazione clinica dell'efficacia terapeutica dell'acebutololo nell'ipertensione arteriosa. 66
Metformin and kidney 66
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 65
Alterazioni carotidee nell’insufficienza renale cronica 65
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism 64
Review: UPDATE sul metabolismo del magnesio 64
Complicanze tardive legate al posizionamento del catetere venoso centrale: le complicanze meccaniche 64
Aspergillosis in Hemodialysis Patient 64
Alterazioni carotidee in corso di insufficienza renale cronica 64
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 64
La PET con C-Metionina: un approccio propositivo nel trattamento dell'iperparatiroidismo 63
Heart rate, age and the risk progression to kidney failure in patients with CKD 62
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients 62
DIAGNOSTIC POTENZIAL OF CARDIAC NATRIURETIC PEPTIDES IN DIALYSIS PATIENTS 62
An Unusual Association: Fahr's Syndrome And Chronic Kidney Disease 62
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease 61
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 61
Comparative study of biochemical markers of bone formation in relation to different dialysis age 60
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study 60
IL2 and its receptors in elderly subjects on hemodialysis 60
DOES DIASTOLIC HEART FUNCTION INTERFERE WITH PERITONEAL CA-125 IN CAPD 60
MANUALE ITALIANO DI CATETERISMO VENOSO CENTRALE IN NEFROLOGIA 60
Psichiatria di Liaison:Contributo sperimentale allo studio della Qualità di dei DializzatiVita 59
Magnesium, calcium and potassium: "no one was born alone" 59
STUDIO SIR-SIN ( STUDIO ITALIANO INDICATORI DI RISULTATO MULTIPLI-EPIDEMIOLOGIA DELL’IRC IN ITALIA DELLA SOCIETA’ ITALIANA DI NEFROLOGIA) NELLA POPOLAZIONE AFFETTA DA IRC IN TERAPIA CONSERVATIVA. DATI PRELIMINARI 59
Ruolo della Dialisi Peritoneale nel trattamento dei Pazienti con Scompenso Cardiaco Congestizio 59
Sepsi e Polimixina (contributo) 59
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 59
Comportamento delle transaminasi sieriche in corso di infezione da HBV e HCV in pazienti emodializzati 58
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 58
Oi Dialogoi in Dialisi Peritoneale 58
CHLAMYDIA PNEUMONIAE, OVERALL AND CARDIOVASCULAR MORTALITY IN END STAGE RENAL DISEASE 57
Pyelonephritis: Epidemiology, pathogenesis and managemen 57
Exit-site infetto con Proud-Flesh:quale terapia? 57
L’interleuchina-6 è implicata in maniera causale nell’alto rischio cardiovascolare della malattia renale cronica: uno studio di randomizzazione mendeliana 57
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients 57
The effect of tumor necrosis factor antagonists on functional aortic stiffening 57
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure 57
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 57
Renal function and ultrasound imaging in elderly subjects 57
Color Doppler ultrasound and arteriovenous fistulas for hemodialysis. 56
GESTIONE CLINICA DELL’IRC: DATI CAMPANO-SICILIANI DELLO STUDIO TABLE 56
Ultrasuoni versus rx nella dislocazione del catetere peritoneale: mito o raltà? 56
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients. 56
ADPKD:rilevanza del rischio cardio-vascolare in un gruppo di pazienti non complianti alla terapia antipertensiva. 56
Ascessi Renali:patologia emergente in soggetti di giovane età 56
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the excite trial 55
Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease 55
Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease 55
LE NUOVE SOLUZIONI IN DIALISI PERITONEALE 55
L'anziano dializzato " solo ". 55
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 55
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? 54
Renal transplantation parenchymal complications: what Doppler ultrasound can and cannot do 54
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 54
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 54
THE ENDOGENOUS INHIBITOR OFF e NOs ASIMMETRIC DIMETHYLARGININE (ADMA) IS HIGHER IN CAPD THAN IN HD PATIENTS 54
Il paradosso nefrologico 54
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. 54
Il fumo, la pressione arteriosa e l'albuminemia sono fattori predittivi indipendenti dal danno vascolare negli uremici in dialisi 53
Totale 7.807
Categoria #
all - tutte 45.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 0 0 0 0 0 0 0 0 0 0 133 71
2020/20211.439 34 133 186 34 369 39 168 10 222 14 175 55
2021/20221.695 227 253 4 22 265 12 248 63 171 1 41 388
2022/20232.328 252 71 37 185 218 463 5 385 603 17 73 19
2023/2024968 62 205 63 61 34 109 27 51 4 38 210 104
2024/20253.267 38 632 244 163 826 403 44 153 335 422 7 0
Totale 12.902